Shopping Cart
- Remove All
- Your shopping cart is currently empty
SAFit2 is a highly potent and selective inhibitor of fk506 binding protein 51 (FKBP51) with a Ki value of 6 nM. SAFit2 can enhance the binding of AKT2-AS160 and participate in the downstream response of glucocorticoid release in vivo. It is a candidate compound for the treatment of obesity, chronic pain, depression and anxiety.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $80 | In Stock | |
5 mg | $197 | In Stock | |
10 mg | $297 | In Stock | |
25 mg | $493 | In Stock | |
50 mg | $718 | In Stock | |
100 mg | $993 | 8-10weeks | |
1 mL x 10 mM (in DMSO) | $262 | In Stock |
Description | SAFit2 is a highly potent and selective inhibitor of fk506 binding protein 51 (FKBP51) with a Ki value of 6 nM. SAFit2 can enhance the binding of AKT2-AS160 and participate in the downstream response of glucocorticoid release in vivo. It is a candidate compound for the treatment of obesity, chronic pain, depression and anxiety. |
Targets&IC50 | FKBP51:6 nM(ki) |
In vitro | METHODS: The effects of SAFit2 (1, 5, 10 μM) on macrophage migration were evaluated in a Transwell assay. RESULTS SAFit2 significantly reduced macrophage migration in a concentration-dependent manner. [4] |
In vivo | METHODS: SAFit2 (20 mg/kg, intraperitoneal injection, twice a day, 10 days) was administered to mice and glucose tolerance was observed. RESULTS SAFit2 treatment significantly improved glucose tolerance. [1] |
Molecular Weight | 802.99 |
Formula | C46H62N2O10 |
Cas No. | 1643125-33-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90.0 mg/mL (112.1 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.